RSS

Immunocore

T-cell receptor (TCR) company, Immunocore, has announced it will receive $40 million investment from the Bill & Melinda Gates Foundation to accelerate development of its TCR-based therapeutics for infectious diseases. more

News

An immunotherapy clinical trial collaboration is to be undertaken by Immunocore and Eli Lilly and Company, exploring the use of Immunocore’s lead T-cell receptor-based investigational therapeutic, IMCgp100, in combination with Lilly’s galunisertib (L more

News

Biotechnology company Immunocore's chief scientific officer and co-founder Dr. Bent Jakobsen has been recognised for his contribution to medical science with an election to the Fellowship of the Academy of Medical Sciences. more

News

On April 16, 2015, Immunocore Limited, a biotechnology company and MedImmune, the global biologics research and development arm of AstraZeneca, made the announcement that they have have entered into a second collaboration more

News